ALFA FinderBSE filing, BSE: 542934. Summary written from the filing by ALFA Finder's alert engine.
Chandra Bhagat Pharma Ltd: key numbers
- Share price
- ₹55.50
- Market cap
- ₹41.88 Cr
- Revenue (annual)
- ₹116.3 Cr
- Net profit (annual)
- ₹3.05 Cr
- P/E (TTM)
- 13.8×Sector 43.0×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandra Bhagat Pharma Ltd
All →Chandra Bhagat Pharma Board Meeting Date
Chandra Bhagat Pharma Limited has intimated a board meeting on 13 November 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from 1 October to 16 November 2026.
Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 50 lakh convertible warrants worth ₹21.90 Crore to seven promoter group members. Allotment was completed on 22 October 2026.
- Value
- ₹21.90 Cr
Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 66 lakh convertible warrants at Rs.44 each, raising Rs.7.26 Crore from 9 allottees. Warrants are convertible 1:1 into equity shares within 18 months.
- Value
- ₹7.26 Cr
Chandra Bhagat Pharma Other Announcement
Chandra Bhagat Pharma Ltd filed a certificate for non-applicability of corporate governance requirements for the September 2026 quarter. This exemption applies to SME-listed entities.
Chandra Bhagat Pharma Preferential Issue
Chandra Bhagat Pharma received BSE in-principle approval for a preferential issue of 66,00,000 warrants at Rs. 44 each. Total issue value is approximately Rs. 2.90 Crore.
- Value
- ₹2.90 Cr
Chandra Bhagat Pharma Management Change
Ms. Rajani Dawani has resigned from her position as Company Secretary and Compliance Officer of Chandra Bhagat Pharma Limited, effective September 30, 2026.
Other annual report announcements
All →Indrayani Biotech Annual Report
Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.
ESDS Software Solution Annual Report
ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.
The Orissa Minerals Development Company Annual Report
Orissa Minerals Development Company filed its FY 2025-26 Annual Report and 108th AGM notice, with the AGM set for 30 November 2026. The filing is a Regulation 34 intimation with no transaction or financial event.
Viksit Engineering Annual Report
Viksit Engineering filed its 44th Annual Report for FY 2025-26 with BSE. The report includes notice of the AGM on 30 November 2026.
Innovision Annual Report
Innovision Ltd filed its FY2025-26 Annual Report with the notice of its 20th AGM, scheduled for 5 December 2026 via VC/OAVM. The notice covers financial statements, a director re-appointment and a non-executive director regularisation.
Indian Toners & Developers Annual Report
Indian Toners & Developers filed its 2025-26 Annual Report and AGM notice with BSE. The 36th AGM is scheduled for 13 July 2026 at the registered office.